Omnicef and Proventil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Omnicef (cefdinir) and Proventil (albuterol). Common drug interactions include drug ineffective among females and chest discomfort among males.

The phase IV clinical study analyzes what interactions people have when they take Omnicef and Proventil. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Omnicef?

Omnicef has active ingredients of cefdinir. It is often used in sinusitis. eHealthMe is studying from 2,774 Omnicef users. Check the latest studies of Omnicef.

What is Proventil?

Proventil has active ingredients of albuterol. It is often used in asthma. eHealthMe is studying from 16,110 Proventil users. Check the latest studies of Proventil.



On Jul, 10, 2026

26 people who take Omnicef and Proventil together, and have interactions are studied.

Omnicef and Proventil drug interactions.

What are the common drug interactions of Omnicef and Proventil, by gender? *:

female:

  1. Drug ineffective
  2. Dysphonia (speech disorder attributable to a disorder of phonation)
  3. Gait disturbance
  4. Haemoglobin decreased
  5. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  6. Heart rate decreased
  7. Hypersensitivity
  8. Implant site pain
  9. Insomnia (sleeplessness)
  10. International normalised ratio increased

male:

  1. Chest discomfort
  2. Dyspnoea (difficult or laboured respiration)
  3. Blood triglycerides increased
  4. Cardiomegaly (increased size of heart than normal)
  5. Cardiomyopathy (weakening of the heart muscle)
  6. Chest pain
  7. Chronic kidney disease
  8. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  9. Cough
  10. Cytomegalovirus infection

What are the common drug interactions of Omnicef and Proventil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Pain
  2. Pulmonary oedema (fluid accumulation in the lungs)
  3. Tonsillitis (inflammation of tonsil)
  4. Anxiety
  5. Cardiomegaly (increased size of heart than normal)
  6. Cough
  7. Drug abuse
  8. Drug dependence
  9. Hepatosplenomegaly (enlargement of both the liver and the spleen)
  10. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)

30-39:

  1. Chest discomfort
  2. Dyspnoea (difficult or laboured respiration)
  3. Paranasal sinus hypersecretion

40-49:

  1. Chronic kidney disease

50-59:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Angioedema (rapid swelling of the dermis)
  4. Anxiety
  5. Atelectasis (partial or complete collapse of the lung)
  6. Blood pressure decreased
  7. Blood pressure systolic increased
  8. Coma (state of unconsciousness lasting more than six hours)
  9. Drooling (drop saliva uncontrollably from the mouth)
  10. Drug hypersensitivity

60+:

  1. Pain in extremity
  2. Headache (pain in head)
  3. Abdominal discomfort
  4. Anaemia of chronic disease
  5. Breast cancer metastatic
  6. Cardiac failure congestive
  7. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  8. Disease progression
  9. Dyspnoea (difficult or laboured respiration)
  10. Essential hypertension (primary hypertension)

What are the existing conditions these people have? *

  1. Wheezing (a high-pitched whistling sound made while you breath): 10 people, 38.46%
  2. Constipation: 10 people, 38.46%
  3. Migraine (headache): 10 people, 38.46%
  4. Neuralgia (pain in one or more nerves): 10 people, 38.46%
  5. Pain: 9 people, 34.62%
  6. Dyspnea (difficult or laboured breathing): 9 people, 34.62%
  7. Fibromyalgia (a long-term condition which causes pain all over the body): 9 people, 34.62%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 34.62%
  9. Back Pain: 8 people, 30.77%
  10. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 8 people, 30.77%

* Approximation only. Some reports may have incomplete information.

Do you take Omnicef and Proventil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Omnicef and Proventil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Omnicef:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Proventil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Omnicef and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Proventil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cefdinir and albuterol (the active ingredients of Omnicef and Proventil, respectively), and Omnicef and Proventil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: